glp-1 agonist drugs oral Market Overview: Agonists and the Obesity Market | Blog Oral GLP-1: A Needle-Free Solution
Description
September 25, 2025
They can be used to treat type 2 diabetes and reduce the risk of heart disease
[DOI] [PMC free article] [PubMed] [Google Scholar] 40.Pediatric Endocrine Society Obesity Committee
If needle phobia is a particular issue, discussion of options that have the needle hidden and/or have a pre-attached needle, which require minimal handling by the patient, could be considered
Overall, therapeutic inertia was observed in 38.0% of the study population
Thiazolidinediones have been associated with a reduced risk of certain cancers, although concerns over their safety continue to be debated
